The AWS Kiro team today is announcing v2.0, which delivers a headless mode, Windows support and an updated, refreshed user ...

AWS announced the launch of its AI bio tool, Amazon Bio Discovery, to accelerate the early-stage process of drug discovery.

Q2 Holdings has introduced Q2 Code, a new AI-powered development environment built in collaboration with Anthropic and Amazon Web Services, signaling a deeper shift in how software is created inside ...

A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster.